Search by Drug Name or NDC

    NDC 00409-1626-01 Butorphanol Tartrate 2 mg/mL Details

    Butorphanol Tartrate 2 mg/mL

    Butorphanol Tartrate is a INTRAMUSCULAR; INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Hospira, Inc.. The primary component is BUTORPHANOL TARTRATE.

    Product Information

    NDC 00409-1626
    Product ID 0409-1626_e889573a-2745-485a-878b-8b9a3fff682e
    Associated GPIs 65200020102010
    GCN Sequence Number 004288
    GCN Sequence Number Description butorphanol tartrate VIAL 2 MG/ML INJECTION
    HIC3 H3A
    HIC3 Description OPIOID ANALGESICS
    GCN 16551
    HICL Sequence Number 001777
    HICL Sequence Number Description BUTORPHANOL TARTRATE
    Brand/Generic Generic
    Proprietary Name Butorphanol Tartrate
    Proprietary Name Suffix n/a
    Non-Proprietary Name Butorphanol Tartrate
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, SOLUTION
    Route INTRAMUSCULAR; INTRAVENOUS
    Active Ingredient Strength 2
    Active Ingredient Units mg/mL
    Substance Name BUTORPHANOL TARTRATE
    Labeler Name Hospira, Inc.
    Pharmaceutical Class Competitive Opioid Antagonists [MoA], Opioid Agonist/Antagonist [EPC], Partial Opioid Agonists [MoA]
    DEA Schedule CIV
    Marketing Category ANDA
    Application Number ANDA074626
    Listing Certified Through 2025-12-31

    Package

    NDC 00409-1626-01 (00409162601)

    NDC Package Code 0409-1626-01
    Billing NDC 00409162601
    Package 10 VIAL, SINGLE-DOSE in 1 CARTON (0409-1626-01) / 1 mL in 1 VIAL, SINGLE-DOSE (0409-1626-21)
    Marketing Start Date 2006-03-17
    NDC Exclude Flag N
    Pricing Information N/A